"This lengthy order instructs a range of executive actors to engage in drug pricing-related issues, both on their own and through working with Congress.... [T]his article [will] explain and analyze the most significant policies discussed in the executive order, placing them in context with previous drug pricing reform efforts, and assess the potential impact of these efforts."  MORE >>

"On April 10, 2025, the Cook County Board of Commissioners approved further revisions to the ... regulations implementing the county's paid leave ordinance.... [1] No accrual of paid leave when using paid leave ... [2] Pay date when paid leave used ... [3] Additional benefits when using paid leave ... [4] Use if employee suspended or placed on disciplinary leave ."  MORE >>

"These cases underscore the tension between corporate governance, employee benefits, and the obligation of fiduciaries to act solely in the best interest of plan participants. They also illustrate the potential ripple effect of fiduciary litigation, prompting calls for transparency and prudent management ... But what exactly does it mean to be a prudent fiduciary? And how does one act in the best interest of the Plan and its participants?"  MORE >>

"[Arkansas HB 1150] prohibits state permits to pharmacies owned by pharmacy benefit managers effective Jan. 1, 2026.... [S]imilar ownership provisions [have been] introduced or amended into bills in Indiana, New York, Texas, and Vermont.... [A] bipartisan coalition of 39 state and territory attorneys general sent a letter to congressional leaders urging them to pass legislation prohibiting PBMs from owning or operating pharmacies."  MORE >>

"State regulations on PBMs are expanding, but ERISA preemption adds an additional layer of analysis, especially for self-insured plans.... To stay compliant, employer plan sponsors should work closely with their carriers, PBMs and ERISA counsel to understand their legal responsibilities around the growing number of state laws."  MORE >>

"In the new executive order, the Secretary of HHS is directed to work with Congress to implement a change in the Medicare Drug Price Negotiation Program [that would] delay negotiation of so-called 'small molecule' drugs beyond 7 years after FDA approval under current law. This change ... could lead to higher Medicare prescription drug spending, higher prices, and potentially higher Medicare Part D premiums."  MORE >>

"Employers and insurers can help deliver peace of mind to their employees by simply maintaining free access to these services regardless of what the Supreme Court rules.... At the same time, insurers and employers can use their influence to encourage state governments to codify these protections for as many people as possible and advocate for the Supreme Court to keep this mandate intact."  MORE >>